Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Junying Yuan, John Ornell, Eugene Cassis

Premium

Agilent this week awarded Chinese Academy of Sciences researcher Junying Yuan an Agilent Thought Leader award in recognition of her research in cellular biology and neurodegenerative diseases.

Yuan and her team use mass spectrometry to study interactions of metabolite-protein, protein-protein and genetic networks involved in the etiology of neurodegenerative disease. Primarily focused on metabolomics, she now plans to integrate her lab's metabolomic data with transcriptomic and proteomic data with the aim of identifying protein targets or biomarkers linked to neurodegenerative disease.


Waters' John Ornell plans to resign from his post as chief financial officer, effective Feb. 1, 2014, after which he will continue to serve the company as an advisor on a part-time basis.

Eugene Cassis, who currently is corporate VP of worldwide business development and investor relations, will step into the CFO role on an interim basis when Ornell leaves the position. Cassis has been with the company for 33 years and has an extensive background in the firm's financial, operational, and technical activities.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.